CD8A and neoplasm: Of note, in both hormone-dependent and independent BC cell lines and in xenograft mice, Li et al. reported a notable enhancement of anti-tumor cytotoxicity by CD8+ T cells transduced with an MHC-A2-restricted placenta-specific 1 (PLAC1)-TCR molecule (38).